New England dispensary members ( n = 1,513) completed an online survey about their medical history and medical cannabis [MC] experiences. Among respondents that regularly used opioids, over three-quarters (76.7%) indicated that they reduced their use since they started MC. Approximately two-thirds of patients decreased their use of anti-anxiety (71.8%), migraine (66.7%), and sleep (65.2%) medications following MC.
Another interesting finding was that the patient’s spouse, family, and other friends were more likely to know about their MC use than was their primary care provider.
J Psychopharmacol. 2017 Mar 1:269881117699616. doi: 10.1177/0269881117699616. [Epub ahead of print]
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.
Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman C, Perkinson L, Lynn ST, Nichols SD, Abess AT